MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2019 International Congress

    How reliable are non-blinded evaluations of motor UPDRS? a comparison of blinded vs. un-blinded UPDRS scores in 14 patients with advanced Parkinson´s disease

    G-M. Hariz, A. Fredricks, R. Stenmark, J. Linder, M. Hariz, L. Forsgren, P. Blomstedt (Umea, Sweden)

    Objective: To investigate the reliability of scores of the motor part of the Unified Parkinson Disease Rating Scale (UPDRS III) rated by an un-blinded specialist…
  • 2019 International Congress

    Digital monitoring of Huntington’s disease with smartphone and smartwatch wearable technology: The Digital-HD study

    R. Tortelli, T. Kilchenmann, F. Rodrigues, L. Byrne, A. Bamdadian, F. Lipsmeier, S. Schobel, M. Lindemann, E. Wild (London, United Kingdom)

    Objective: To investigate the tolerability and feasibility of using wearable smartphone and smartwatch technologies to monitor the motor, behavioural, cognitive and quality of life (QoL)…
  • 2019 International Congress

    Communication Calendar for Interdisciplinary Therapy of Parkinson’s Disease

    F. Adib Saberi, D. Dressler (Hamburg, Germany)

    Objective: To develop a communication calendar (CC) to facilitate information exchange amongst therapists involved in interdisciplinary therapy of Parkinson's Disease (PD). Background: Increasing complexity of…
  • 2019 International Congress

    Composite UHDRS shows extensive spatial correlation with grey matter and white matter volume in Huntington’s disease gene carriers

    C. Estevez-Fraga, E. Johnson, F. Rodrigues, P. Zeun, A. Durr, D. Langbehn, B. Leavitt, R. Roos, S. Gregory, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

    Objective: This work sought to determine the structural correlates of variability in cUHDRS in HD gene expansion carriers (HDGC). Background: Symbol digit modalities test (SDMT),…
  • 2019 International Congress

    Novel exploratory outcome assessments in GENERATION HD1

    D. Trundell, S. Schobel, R. Roos, K. Anderson, A. Thobhani, G. Hooper, M. Nguyen, S. Tabrizi (Welwyn Garden City, United Kingdom)

    Objective: To improve collection of outcomes meaningful to patients with Huntington’s disease (HD) and their families, through the development of novel assessments of daily functional…
  • 2019 International Congress

    Vascular Parkinsonism and Parkinson’s Disease: clinical differences concerning balance impairment

    R. Jesus, R. Raimundo, C. Azoia, M. Mendes, V. Espirito-Santo, A. Almeida, I. Rego, AG. Velon (Vila Real, Portugal)

    Objective: Determine and compare lower body predominance and balance between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD)patients in a hospital-based sample. Background: Despite the recognition…
  • 2019 International Congress

    Using functional status to aid interpretation of cUHDRS scores in patients with Huntington’s disease

    D. Trundell, G. Palermo, J. Long, B. Leavitt, S. Schobel, S. Tabrizi (Welwyn Garden City, United Kingdom)

    Objective: To enhance understanding of the composite Unified Huntington’s Disease Rating Scale (cUHDRS) scoring by linking to established measures of meaningful daily function and independence…
  • 2019 International Congress

    The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change

    I. Piot, K. Schweyer, G. Respondek, M. Grimm, M. Stamelou, P. Sckopke, T. Schenk, C. Goetz, G. Stebbins, G. Höglinger (Munich, Germany)

    Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…
  • 2019 International Congress

    Assessment of Caregiver Burden in Huntington’s disease

    M. Yu, K. Tan, K. Koloms, D. Bega (Chicago, IL, USA)

    Objective: We aim to identify and characterize caregiver burden among HD caregivers, to see what aspects of HD caregiving are associated with the greatest burden…
  • 2019 International Congress

    A characterization of the ADL-level in daily life with Parkinson`s Disease based on objective measurements and subjective experiences.

    T. Thomsen, T. Kjær, L. Jørgensen, A. Haahr, K. Winge (Roskilde, Denmark)

    Objective: 1. Test whether slow response to the medication and EMO-periods (Early Morning Off), affects the patient`s experience of being able to perform ADL-functions. 2.…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley